Safe and Effective Sarcoma Therapy through Bispecific Targeting of EGFR and uPAR.
about
Evaluation of 18-F-fluoro-2-deoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) as a staging and monitoring tool for dogs with stage-2 splenic hemangiosarcoma - A pilot study.Canine Soft Tissue Sarcomas: Can Being a Dog's Best Friend Help a Child?Targeting pediatric sarcoma with a bispecific ligand immunotoxin targeting urokinase and epidermal growth factor receptors.Targeting EGFR and uPAR on human rhabdomyosarcoma, osteosarcoma, and ovarian adenocarcinoma with a bispecific ligand-directed toxin
P2860
Safe and Effective Sarcoma Therapy through Bispecific Targeting of EGFR and uPAR.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Safe and Effective Sarcoma Therapy through Bispecific Targeting of EGFR and uPAR.
@en
type
label
Safe and Effective Sarcoma Therapy through Bispecific Targeting of EGFR and uPAR.
@en
prefLabel
Safe and Effective Sarcoma Therapy through Bispecific Targeting of EGFR and uPAR.
@en
P2093
P2860
P50
P1476
Safe and Effective Sarcoma Therapy through Bispecific Targeting of EGFR and uPAR.
@en
P2093
Aaron L Sarver
Amber L Winter
Anthony E Rizzardi
Antonella Borgatti
Colleen L Forster
Daniel A Vallera
Deborah Todhunter
Jerry Froelich
Jillian Walz
P2860
P304
P356
10.1158/1535-7163.MCT-16-0637
P577
2017-02-13T00:00:00Z